186 related articles for article (PubMed ID: 34721036)
1. Tanreqing Inhibits LPS-Induced Acute Lung Injury
He YQ; Zhou CC; Deng JL; Wang L; Chen WS
Front Pharmacol; 2021; 12():746964. PubMed ID: 34721036
[TBL] [Abstract][Full Text] [Related]
2. Tanreqing injection protects against bleomycin-induced pulmonary fibrosis via inhibiting STING-mediated endoplasmic reticulum stress signaling pathway.
Deng J; He Y; Sun G; Yang H; Wang L; Tao X; Chen W
J Ethnopharmacol; 2023 Apr; 305():116071. PubMed ID: 36584920
[TBL] [Abstract][Full Text] [Related]
3. Perillaldehyde ameliorates lipopolysaccharide-induced acute lung injury via suppressing the cGAS/STING signaling pathway.
Wei J; Liu Z; Sun H; Xu L
Int Immunopharmacol; 2024 Mar; 130():111641. PubMed ID: 38368770
[TBL] [Abstract][Full Text] [Related]
4. Systems pharmacology-based study of Tanreqing injection in airway mucus hypersecretion.
Liu W; Zhang X; Mao B; Jiang H
J Ethnopharmacol; 2020 Mar; 249():112425. PubMed ID: 31765763
[TBL] [Abstract][Full Text] [Related]
5. Apigenin Suppresses Innate Immune Responses and Ameliorates Lipopolysaccharide-Induced Inflammation via Inhibition of STING/IRF3 Pathway.
Zhou XW; Wang J; Tan WF
Am J Chin Med; 2024; 52(2):471-492. PubMed ID: 38480499
[TBL] [Abstract][Full Text] [Related]
6. Tanreqing injection inhibits dengue virus encephalitis by suppressing the activation of NLRP3 inflammasome.
Huang H; He X; Shi L; Yu J; Lu Z; Cao H; Ou J; Chen X; Yan L; Yang J; Zhao W; Liu J; Yu L
Chin Med; 2024 Feb; 19(1):24. PubMed ID: 38355571
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Fpr2 expression protects against endotoxin-induced acute lung injury by interacting with Nrf2-regulated TAK1 activation.
Liu H; Lin Z; Ma Y
Biomed Pharmacother; 2020 May; 125():109943. PubMed ID: 32106380
[TBL] [Abstract][Full Text] [Related]
8. Blocking of tripartite motif 8 protects against lipopolysaccharide (LPS)-induced acute lung injury by regulating AMPKα activity.
Xiaoli L; Wujun Z; Jing L
Biochem Biophys Res Commun; 2019 Jan; 508(3):701-708. PubMed ID: 30527811
[TBL] [Abstract][Full Text] [Related]
9. Bardoxolone treatment alleviates lipopolysaccharide (LPS)-induced acute lung injury through suppressing inflammation and oxidative stress regulated by Nrf2 signaling.
Pei X; Zhang XJ; Chen HM
Biochem Biophys Res Commun; 2019 Aug; 516(1):270-277. PubMed ID: 31248593
[TBL] [Abstract][Full Text] [Related]
10. Protective Effects of
Zhang Y; Han Z; Jiang A; Wu D; Li S; Liu Z; Wei Z; Yang Z; Guo C
Front Pharmacol; 2020; 11():591836. PubMed ID: 33633565
[TBL] [Abstract][Full Text] [Related]
11. The STING-IRF3 pathway contributes to paraquat-induced acute lung injury.
Wang N; Wang X; Li Y; Shen H; Liu Z; Ma Z; Li Q; Zhao M
Toxicol Mech Methods; 2022 Feb; 32(2):145-157. PubMed ID: 34455893
[TBL] [Abstract][Full Text] [Related]
12. The novel N-methyl-d-aspartate receptor antagonist MN-08 ameliorates lipopolysaccharide-induced acute lung injury in mice.
Jiang J; Jian Q; Jing M; Zhang Z; Zhang G; Shan L; Yu P; Wang Y; Xu L
Int Immunopharmacol; 2019 Jan; 66():109-118. PubMed ID: 30447529
[TBL] [Abstract][Full Text] [Related]
13. CRBN knockdown mitigates lipopolysaccharide-induced acute lung injury by suppression of oxidative stress and endoplasmic reticulum (ER) stress associated NF-κB signaling.
Yang H; Song Z; Hong D
Biomed Pharmacother; 2020 Mar; 123():109761. PubMed ID: 31865141
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-18 binding protein attenuates lipopolysaccharide-induced acute lung injury in mice via suppression NF-κB and activation Nrf2 pathway.
Zhang LM; Zhang J; Zhang Y; Wang L; Fei C; Yi ZW; Dong L
Biochem Biophys Res Commun; 2018 Nov; 505(3):837-842. PubMed ID: 30301527
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology combined with pharmacodynamics revealed the anti-inflammatory mechanism of Tanreqing capsule against acute-exacerbation chronic obstructive pulmonary disease.
Han XX; Tian YG; Liu XF; Zhao D; Du XH; Dong HR; Feng SX; Li JS
Sci Rep; 2022 Aug; 12(1):13967. PubMed ID: 35978041
[TBL] [Abstract][Full Text] [Related]
16. Tanreqing injection inhibits influenza virus replication by promoting the fusion of autophagosomes with lysosomes: An integrated pharmacological study.
Guo R; Liu H; Su R; Mao Q; Zhao M; Zhang H; Mu J; Zhao N; Wang Y; Hao Y
J Ethnopharmacol; 2024 Sep; 331():118159. PubMed ID: 38677572
[TBL] [Abstract][Full Text] [Related]
17. Protective Effects of Dioscin against Lipopolysaccharide-Induced Acute Lung Injury through Inhibition of Oxidative Stress and Inflammation.
Yao H; Sun Y; Song S; Qi Y; Tao X; Xu L; Yin L; Han X; Xu Y; Li H; Sun H; Peng J
Front Pharmacol; 2017; 8():120. PubMed ID: 28377715
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of LPS-induced acute lung injury by continentalic acid in rodents through inhibition of inflammatory mediators correlates with increased Nrf2 protein expression.
Ali H; Khan A; Ali J; Ullah H; Khan A; Ali H; Irshad N; Khan S
BMC Pharmacol Toxicol; 2020 Nov; 21(1):81. PubMed ID: 33239093
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
Niu X; Zang L; Li W; Xiao X; Yu J; Yao Q; Zhao J; Ye Z; Hu Z; Li W
Int Immunopharmacol; 2020 Apr; 81():106024. PubMed ID: 31784404
[TBL] [Abstract][Full Text] [Related]
20. 4-PBA inhibits LPS-induced inflammation through regulating ER stress and autophagy in acute lung injury models.
Zeng M; Sang W; Chen S; Chen R; Zhang H; Xue F; Li Z; Liu Y; Gong Y; Zhang H; Kong X
Toxicol Lett; 2017 Apr; 271():26-37. PubMed ID: 28245985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
